Publicacions en què col·labora amb ANA MARÍA MARTÍNEZ DÍAZ (4)

2014

  1. Targeting tamoxifen to breast cancer xenograft tumours: Preclinical efficacy of folate-attached nanoparticles based on alginate-cysteine/disulphide- bond-reduced albumin

    Pharmaceutical Research, Vol. 31, Núm. 5, pp. 1264-1274

2013

  1. β-N-methylamino-l-alanine causes neurological and pathological phenotypes mimicking Amyotrophic Lateral Sclerosis (ALS): The first step towards an experimental model for sporadic ALS

    Environmental Toxicology and Pharmacology, Vol. 36, Núm. 2, pp. 243-255

  2. β-n-methylamino-L-alanine induces changes in both GSK3 and TDP-43 in human neuroblastoma

    Journal of Toxicological Sciences

2012

  1. Enhanced preclinical efficacy of tamoxifen developed as alginate-cysteine/disulfide bond reduced albumin nanoparticles

    International Journal of Pharmaceutics, Vol. 436, Núm. 1-2, pp. 574-581